Cargando…
PB2230: EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429259/ http://dx.doi.org/10.1097/01.HS9.0000851748.27564.18 |
| _version_ | 1784779384745361408 |
|---|---|
| author | Karimi, M. Zarei, T. Haghpanah, S. Azarkeivan, A. Naderi, M. Matin, S. Bazrafshan, A. Zahedi, Z. Shirkavand, A. Pishdad, P. De Sanctis, V. |
| author_facet | Karimi, M. Zarei, T. Haghpanah, S. Azarkeivan, A. Naderi, M. Matin, S. Bazrafshan, A. Zahedi, Z. Shirkavand, A. Pishdad, P. De Sanctis, V. |
| author_sort | Karimi, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429259 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94292592022-08-31 PB2230: EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Karimi, M. Zarei, T. Haghpanah, S. Azarkeivan, A. Naderi, M. Matin, S. Bazrafshan, A. Zahedi, Z. Shirkavand, A. Pishdad, P. De Sanctis, V. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429259/ http://dx.doi.org/10.1097/01.HS9.0000851748.27564.18 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Karimi, M. Zarei, T. Haghpanah, S. Azarkeivan, A. Naderi, M. Matin, S. Bazrafshan, A. Zahedi, Z. Shirkavand, A. Pishdad, P. De Sanctis, V. PB2230: EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT |
| title | PB2230: EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT |
| title_full | PB2230: EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT |
| title_fullStr | PB2230: EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT |
| title_full_unstemmed | PB2230: EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT |
| title_short | PB2230: EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT |
| title_sort | pb2230: efficacy and safety of sinopharm vaccine for sars-cov-2 and breakthrough infections in iranian patients with hemoglobinopathies: a preliminary report |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429259/ http://dx.doi.org/10.1097/01.HS9.0000851748.27564.18 |
| work_keys_str_mv | AT karimim pb2230efficacyandsafetyofsinopharmvaccineforsarscov2andbreakthroughinfectionsiniranianpatientswithhemoglobinopathiesapreliminaryreport AT zareit pb2230efficacyandsafetyofsinopharmvaccineforsarscov2andbreakthroughinfectionsiniranianpatientswithhemoglobinopathiesapreliminaryreport AT haghpanahs pb2230efficacyandsafetyofsinopharmvaccineforsarscov2andbreakthroughinfectionsiniranianpatientswithhemoglobinopathiesapreliminaryreport AT azarkeivana pb2230efficacyandsafetyofsinopharmvaccineforsarscov2andbreakthroughinfectionsiniranianpatientswithhemoglobinopathiesapreliminaryreport AT naderim pb2230efficacyandsafetyofsinopharmvaccineforsarscov2andbreakthroughinfectionsiniranianpatientswithhemoglobinopathiesapreliminaryreport AT matins pb2230efficacyandsafetyofsinopharmvaccineforsarscov2andbreakthroughinfectionsiniranianpatientswithhemoglobinopathiesapreliminaryreport AT bazrafshana pb2230efficacyandsafetyofsinopharmvaccineforsarscov2andbreakthroughinfectionsiniranianpatientswithhemoglobinopathiesapreliminaryreport AT zahediz pb2230efficacyandsafetyofsinopharmvaccineforsarscov2andbreakthroughinfectionsiniranianpatientswithhemoglobinopathiesapreliminaryreport AT shirkavanda pb2230efficacyandsafetyofsinopharmvaccineforsarscov2andbreakthroughinfectionsiniranianpatientswithhemoglobinopathiesapreliminaryreport AT pishdadp pb2230efficacyandsafetyofsinopharmvaccineforsarscov2andbreakthroughinfectionsiniranianpatientswithhemoglobinopathiesapreliminaryreport AT desanctisv pb2230efficacyandsafetyofsinopharmvaccineforsarscov2andbreakthroughinfectionsiniranianpatientswithhemoglobinopathiesapreliminaryreport |